Vesigen
Latest round
- Series A
Last raised
- Jul 2020
Total raised
- $29M
Investors
- 4
About Vesigen
Vesigen, Inc.Vesigen, Inc. was founded in 2019 and is based in Cambridge, US. The company specializes in epigenetic reprogramming therapies. Robert Millman serves as both the founder and CEO.Vesigen, Inc. specializes in epigenetic reprogramming therapies aimed at restoring cellular function and addressing age-related conditions. The core product offerings include the ERA® technology, which uses mRNA to influence the cellular epigenome, and the eTurna® lipid nanoparticle (LNP) delivery platform designed for targeted therapy delivery. The company has recently acquired the ARMMs (ARRDC1 Mediated Microvesicles) technology, enhancing its delivery capabilities for larger and more diverse therapeutic cargoes.Vesigen operates on a transactional model that involves partnerships and collaborations with academic institutions and commercial entities. Revenue is generated through licensing agreements, allowing clients access to proprietary technologies like the ARMMs delivery platform and the eTurna LNP system. The company aims to expand into new geographic markets, specifically targeting regions in North America and Europe, with strategic initiatives expected to unfold as the company progresses in its developmental timeline.
Who invested in Vesigen
4 investors across 1 round
See all investors in Vesigen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 22, 2020
Amount
$29M
Investors
Questions about Vesigen
Who invested in Vesigen?
Vesigen has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vesigen raised?
Vesigen has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Vesigen last raise money?
Vesigen's most recent round on record is a Series A, in Jul 2020.
What does Vesigen do?
Vesigen is a biotechnology company.
Where is Vesigen headquartered?
Vesigen is headquartered in Cambridge, US.
Which VCs invest in companies like Vesigen?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Vesigen's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Vesigen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.